Growth Metrics

Oculis Holding AG (OCS) Profit After Tax Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 65.80%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -290.15%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 59.59%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -10.08%
8 Evaxion A 65.12 Bn 65.10 Bn - -129.68%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1,228.66%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 0.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.26%
Dec 31, 2025 10.06%
Sep 30, 2025 9.58%
Jun 30, 2025 -33.01%
Mar 31, 2025 -100.36%
Dec 31, 2024 -132.14%
Sep 30, 2024 -118,106.55%
Jun 30, 2024 -60.90%
Mar 31, 2024 62.94%
Dec 31, 2023 -47.82%
Sep 30, 2023 -91.27%
Jun 30, 2023 -11.74%